These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9600212)

  • 21. A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein.
    Calderon TM; Eugenin EA; Lopez L; Kumar SS; Hesselgesser J; Raine CS; Berman JW
    J Neuroimmunol; 2006 Aug; 177(1-2):27-39. PubMed ID: 16782208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions.
    van Horssen J; Drexhage JA; Flor T; Gerritsen W; van der Valk P; de Vries HE
    Free Radic Biol Med; 2010 Nov; 49(8):1283-9. PubMed ID: 20673799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Update on the Role of Matrix Metalloproteinases in the Pathogenesis of Multiple Sclerosis.
    Boziki M; Grigoriadis N
    Med Chem; 2018 Feb; 14(2):155-169. PubMed ID: 28875862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The extracellular matrix of gliomas: modulation of cell function.
    Gladson CL
    J Neuropathol Exp Neurol; 1999 Oct; 58(10):1029-40. PubMed ID: 10515226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting of ECM molecules and their metabolizing enzymes and receptors for the treatment of CNS diseases.
    Berezin V; Walmod PS; Filippov M; Dityatev A
    Prog Brain Res; 2014; 214():353-88. PubMed ID: 25410365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glutamate, T cells and multiple sclerosis.
    Levite M
    J Neural Transm (Vienna); 2017 Jul; 124(7):775-798. PubMed ID: 28236206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple sclerosis - remyelination failure as a cause of disease progression.
    Hagemeier K; Brück W; Kuhlmann T
    Histol Histopathol; 2012 Mar; 27(3):277-87. PubMed ID: 22237705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The extracellular matrix: Focus on oligodendrocyte biology and targeting CSPGs for remyelination therapies.
    Pu A; Stephenson EL; Yong VW
    Glia; 2018 Sep; 66(9):1809-1825. PubMed ID: 29603376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracellular matrix composition determines astrocyte responses to mechanical and inflammatory stimuli.
    Johnson KM; Milner R; Crocker SJ
    Neurosci Lett; 2015 Jul; 600():104-9. PubMed ID: 26067407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix metalloproteinase-12 is expressed in phagocytotic macrophages in active multiple sclerosis lesions.
    Vos CM; van Haastert ES; de Groot CJ; van der Valk P; de Vries HE
    J Neuroimmunol; 2003 May; 138(1-2):106-14. PubMed ID: 12742660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis.
    Motavaf M; Sadeghizadeh M; Javan M
    Cell Mol Neurobiol; 2017 Nov; 37(8):1335-1348. PubMed ID: 28224237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent insights into the pathology of multiple sclerosis and neuromyelitis optica.
    Wegner C
    Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S38-41. PubMed ID: 24321153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibronectin in multiple sclerosis lesions.
    Sobel RA; Mitchell ME
    Am J Pathol; 1989 Jul; 135(1):161-8. PubMed ID: 2528301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA; Akirav EM
    J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MALDI imaging mass spectrometry analysis-A new approach for protein mapping in multiple sclerosis brain lesions.
    Maccarrone G; Nischwitz S; Deininger SO; Hornung J; König FB; Stadelmann C; Turck CW; Weber F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1047():131-140. PubMed ID: 27461358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matrix metalloproteinase-19 is highly expressed in active multiple sclerosis lesions.
    van Horssen J; Vos CM; Admiraal L; van Haastert ES; Montagne L; van der Valk P; de Vries HE
    Neuropathol Appl Neurobiol; 2006 Dec; 32(6):585-93. PubMed ID: 17083473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions.
    Koning N; Bö L; Hoek RM; Huitinga I
    Ann Neurol; 2007 Nov; 62(5):504-14. PubMed ID: 17879969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination.
    Stidworthy MF; Genoud S; Li WW; Leone DP; Mantei N; Suter U; Franklin RJ
    Brain; 2004 Sep; 127(Pt 9):1928-41. PubMed ID: 15289265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interplay between Cell-Surface Receptors and Extracellular Matrix in Skin.
    Kleiser S; Nyström A
    Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32796709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.